Carrie L. Richardson

Rheumatology

675 N St Clair St Ste 14-100
Galter Pavilion
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Cellular and molecular dysregulation of the esophageal epithelium in systemic sclerosis.

Cellular and molecular dysregulation of the esophageal epithelium in systemic sclerosis.

Journal: JCI insight

Published: July 21, 2026

A wearable biomechanical system for medical evaluation of soft tissue disorders.

A wearable biomechanical system for medical evaluation of soft tissue disorders.

Journal: Science advances

Published: July 15, 2026

REN: Anatomically-Informed Mixture-of-Experts for Interstitial Lung Disease Diagnosis.

REN: Anatomically-Informed Mixture-of-Experts for Interstitial Lung Disease Diagnosis.

Journal: IEEE transactions on medical imaging

Published: June 17, 2026

Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis.

Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis.

Journal: Arthritis care & research

Published: November 21, 2025

Association of Type III and Type VI Collagen Neoepitopes With Disease Severity in Systemic Sclerosis.

Association of Type III and Type VI Collagen Neoepitopes With Disease Severity in Systemic Sclerosis.

Journal: The Journal of rheumatology

Published: November 05, 2025

Long-Term Outcomes of Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Patients With Systemic Sclerosis With Impaired Cardiac Function.

Long-Term Outcomes of Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Patients With Systemic Sclerosis With Impaired Cardiac Function.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 04, 2025

Long-Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function.

Long-Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 04, 2025

Profibrotic monocyte-derived alveolar macrophages as a biomarker and therapeutic target in systemic sclerosis-associated interstitial lung disease.

Profibrotic monocyte-derived alveolar macrophages as a biomarker and therapeutic target in systemic sclerosis-associated interstitial lung disease.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2025

Machine Learning Analysis of Electronic Health Records Identifies Interstitial Lung Disease and Predicts Mortality in Patients with Systemic Sclerosis.

Machine Learning Analysis of Electronic Health Records Identifies Interstitial Lung Disease and Predicts Mortality in Patients with Systemic Sclerosis.

Journal: medRxiv : the preprint server for health sciences

Published: June 12, 2025

Cellular and molecular dysregulation of the esophageal epithelium in systemic sclerosis.

Cellular and molecular dysregulation of the esophageal epithelium in systemic sclerosis.

Journal: JCI insight

Published: May 06, 2025

Systemic Sclerosis-Associated Interstitial Lung Disease: What We Know and How to Incorporate Guidelines Into Clinical Practice.

Systemic Sclerosis-Associated Interstitial Lung Disease: What We Know and How to Incorporate Guidelines Into Clinical Practice.

Journal: Chest

Published: April 14, 2025

Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States.

Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States.

Journal: Annals of the American Thoracic Society

Published: April 10, 2025

Showing 1-12 of 34

Last Updated: 09/26/2026